Clinical trial NCT05723302: Chronic Obstructive Pulmonary Diseases and Proprioceptive Neuromuscular Facilitation
Official title: The Effect of Resistant Proprioceptive Neuromuscular Facilitation Exercises on Respiratory Muscle Strength in Chronic Obstructive Pulmonary Diseases
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Chronic Obstructive Pulmonary Disease
Keywords: COPD
Lead sponsor: Istanbul Medipol University Hospital
Sponsor class: OTHER
Collaborators: name: Mehmet Akif Ersoy Canakkale State Hospital
name: Çanakkale Onsekiz Mart University
First posted: 2023-02-10
Enrollment: 31
Sex: ALL
Minimum age (years): 38
Maximum age (years): 67
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: To investigate the effects of resistant proprioceptive neuromuscular facilitation exercises on physical fitness, respiratory muscle strength, walking distance and quality of life in chronic obstructive pulmonary patients.

Detailed description: The study was carried out between January 2017 and January 2019, with patients followed up with the diagnosis of COPD in Çanakkale Mehmet Akif Ersoy State Hospital and Çanakkale Onsekiz Mart University Medical Faculty Hospital, Department of Chest Diseases. It was approved by Istanbul Medipol University Non-Interventional Clinical Research Ethics Committee (Date: 30.12.2016, Decision No. 573) and was done in accordance with the Declaration of Helsinki. All participants were informed about the purpose of the study, the total duration of treatment and the applications to be made, and a consent form was signed. The study was conducted as a prospective and randomized controlled study, and inclusion and exclusion criteria were determined.

Thirty-five patients diagnosed with COPD were referred to the study, four patients were excluded because they did not meet the inclusion criteria, and the study was conducted with a total of 31 participants.

The 31 patients included in the study were randomized after their initial evaluation and divided into two groups as experimental and control groups. Patients meeting the inclusion criteria were divided into 2 groups. Randomized by ordering by date of application.

Eligibility criteria: Inclusion Criteria:

* To be diagnosed with stage 1, stage 2 and stage 3 COPD according to GOLD (Global Initiative for Obstructive Lung Diseases) criteria
* Having FEV1/FVC \<70% according to pulmonary function test
* Being clinically stable
* Being over 18 years old
* Volunteer to participate in the program

Exclusion Criteria:

* Having a COPD exacerbation in the last 8 weeks
* To have participated in a regular exercise training program in the last 1 year
* Having a musculoskeletal disease and neuromuscular disease that may prevent exercise
* Inability to cooperate for pulmonary function test and respiratory muscle strength measurement
* Being on long-term oxygen therapy

Primary outcomes:
measure: HADS
timeFrame: 10 minutes
Secondary outcomes:
measure: SGRQ
timeFrame: 15 minutes
Other outcomes:
Locations:
city: Çanakkale
country: Turkey
facility: Mehmet Akif Ersoy State Hospital
city: Çanakkale
country: Turkey
facility: Çanakkale Onsekiz Mart University
Study officials:
References: